# Adaptive Biotechnologies
> Adaptive Biotechnologies is a commercial-stage company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its proprietary immune medicine platform reveals and translates the genetic code of the immune system to develop better diagnostics and therapeutics.
- URL: https://optimly.ai/brand/adaptive-biotechnologies
- Slug: adaptive-biotechnologies
- BAI Score: 88/100
- Archetype: Challenger
- Category: Biotechnology
- Last Analyzed: April 10, 2026
## Competitors
- 10x Genomics (https://optimly.ai/brand/10x-genomics)
- Guardant Health (https://optimly.ai/brand/guardant-health)
- Natera (https://optimly.ai/brand/natera)
## Also Referenced By
- Personalis (NeXT Personal) (https://optimly.ai/brand/personalis-next-personal)
## Buyer Intent Signals
Problems: Standard Flow Cytometry/qPCR: Using traditional flow cytometry or specialized PCR to track disease, though with lower sensitivity than NGS. | Standard Clinical Monitoring: Continuing current clinical monitoring without minimal residual disease (MRD) testing, risking missing early relapse. | Specialized CRO Services: Hiring specialized labs or CROs to develop custom assays for specific clinical trials.
Solutions: What is MRD testing in leukemia? | NGS immune repertoire sequencing providers | Best liquid biopsy for solid tumors | T-cell receptor mapping technology | Is clonoSEQ FDA approved?